Medications for Opioid Use Disorder in Correctional Facilities: A 2022 Cross-Sectional Survey of Health Care Staff

View at publisher
Authors: Claire Wolfe, Sabrina Gaiazov, Pamela A. Valera, William Mullen, Ross S. MacDonald, Christian A. Heidbreder
Cited by: 0
References: 29

Abstract

A national, anonymous, online survey was administered inviting 3,161 correctional health professionals to examine the associations between facility characteristics and the availability of medications for opioid use disorder (MOUD) in jails and prisons. Responses from 268 participants representing 212 correctional facilities were analyzed. We used multivariate logistic regression to identify associated facility characteristics, and open-ended responses were analyzed using content analysis. Facilities in the Western United States had higher odds of providing MOUD compared with those in the Midwest (adjusted odds ratio [AOR] = 3.67, 95% confidence interval [CI]: 1.28-10.99). Jails had higher odds of offering MOUD than prisons (AOR = 2.13, OR = 0.47, 95% CI: 0.21-0.99). Qualitative analysis revealed key supports for facilitating MOUD implementation and common barriers.

Fields of Study & Subjects

Opioid Use Disorder Treatment Substance Abuse Treatment and Outcomes Criminal Justice and Corrections Analysis

Publication details

Journal / source
Journal of Correctional Health Care
Volume
32
Issue
2
Pages
132–144
Publication date
4 February 2026
Language
EN